Pacira BioSciences, Inc. (PCRX)

Payables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 199,072 221,200 222,086 211,709 198,991 198,893 209,821 212,241 199,295 176,386 160,359 144,980 140,255 136,546 131,888 118,945 117,328 113,934 106,245 109,141
Payables US$ in thousands
Payables turnover

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $199,072K ÷ $—K
= —

The payables turnover ratio for Pacira BioSciences, Inc. is not provided in the data provided. The payables turnover ratio measures how efficiently a company is managing its accounts payable by comparing the amount of purchases made on credit to the average accounts payable balance during a specific period. This ratio is calculated by dividing the total purchases by the average accounts payable.

Without the specific data on accounts payable and purchases, we are unable to calculate the payables turnover ratio for Pacira BioSciences. Monitoring the payables turnover ratio over time can provide insights into how quickly the company is paying its suppliers and managing its working capital. A higher payables turnover ratio indicates that the company is paying its suppliers more quickly, while a lower ratio suggests that the company is taking longer to pay its bills.

It would be beneficial to have access to the actual accounts payable and purchases data to calculate and analyze the payables turnover ratio for Pacira BioSciences, Inc.